Momenta, Mylan to jointly develop six biosimilars

January 8, 2016 2:10 PM

35 0

Momenta, Mylan to jointly develop six biosimilars

Companies will equally share R&D costs and profits

Mylan NV and Momenta Pharmaceuticals Inc. said Friday they would jointly develop and commercialize six biosimilars.

Also read: For Trump Administration, ‘Extreme Vetting’ Has Wide Scope

Read more

To category page

Loading...